NCT00465049 is a Phase 2 clinical trial of PRIMARY CLOSRE in Cutanoeus Abscesses, sponsored by Stony Brook University.

Who is sponsoring NCT00465049?

NCT00465049 is sponsored by Stony Brook University.

What drugs are being tested in NCT00465049?

Interventions in NCT00465049: PRIMARY CLOSRE, SECONDARY CLOSURE, SPONTANEOUS HALING.

What condition does NCT00465049 study?

NCT00465049 studies Cutanoeus Abscesses.

Is NCT00465049 still recruiting?

NCT00465049 is currently completed. Last updated 19 October 2012.

Last reviewed 2012-10-19 · How we verify

NCT00465049

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Primary vs. Secondary Closure of Cutaneous Abscesses After I&D: A RCT

Completed Phase 2 Last updated 19 October 2012

What this trial tests

Phase 2 trial testing PRIMARY CLOSRE in Cutanoeus Abscesses in 100 participants. Completed in 1 February 2012.

Timeline

1 January 2007

Primary endpoint
1 January 2012

1 February 2012

Quick facts

Lead sponsor	Stony Brook University
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	1 January 2007
Primary completion	1 January 2012
Estimated completion	1 February 2012
Sites	1 location across United States

Drugs / interventions tested

PRIMARY CLOSRE
SECONDARY CLOSURE
SPONTANEOUS HALING

Conditions studied

Cutanoeus Abscesses — all drugs for Cutanoeus Abscesses →

Sponsor

Stony Brook University

Who can join

Adults 18 to 85, any sex, with Cutanoeus Abscesses. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Days to healing.
Time frame: 1 week

Sponsor's own description

The standard treatment for skin abscesses in drainage followed by packing to prevent premature closure and reaccumulation of pus. Studies from the 1950s and later conducted outside of the US suggest that when drained abscesses are drained and sutured closed they actually heal faster without complications. The current study compares the time to healing and scar formation when drained abscesses are packed or sutured.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Stony Brook University trials

Trials by the same sponsor.

NCT07478250 — First Responder Safety Training (FiRST) · NA · not yet recruiting
NCT07076342 — The Role of mGluR5 in CBT-I · Phase 4 · recruiting
NCT07009691 — Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS · NA · recruiting
NCT07114900 — Randomized Controlled Physical Activity App Intervention for Black Women · Phase 3 · active not recruiting
NCT05245227 — Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00465049 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stony Brook University
Last refreshed: 19 October 2012

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00465049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing